Aitchison, Katherine J.
University of Alberta
19 papers on CoChatORCID 0000-0002-1107-3024
Most cited papers
- Verified
Candidate Genes Expression Profile Associated with Antidepressants Response in the GENDEP Study: Differentiating between Baseline ‘Predictors’ and Longitudinal ‘Targets’
Cattaneo, A., Gennarelli, M., Uher, R., Breen, G., Farmer, A., Aitchison, K. J., Craig, I. W., Anacker, C., Zunsztain, P. A., McGuffin, P., et al. (2013) · Neuropsychopharmacology
Treatment of Major DepressionTryptophan and brain disorders
Cited by 436
- Verified
Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms
Uher, R., Perlis, R. H., Henigsberg, N., Zobel, A., Rietschel, M., Mors, O., Hauser, J., Dernovsek, M. Z., Souery, D., Bajs, M., et al. (2012) · Psychological Medicine
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 420
- Verified
Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma
Jiang, S., Postovit, L., Cattaneo, A., Binder, E. B., & Aitchison, K. J. (2019) · Frontiers in Psychiatry
Child Abuse and TraumaEpigenetics and DNA Methylation
Cited by 288
- Verified
Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression
Köhler-Forsberg, O., Buttenschøn, H. N., Tansey, K. E., Maier, W., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., Rietschel, M., et al. (2017) · Brain Behavior and Immunity
Tryptophan and brain disordersTreatment of Major Depression
Cited by 283
- Verified
Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment
Mondelli, V., Dazzan, P., Hepgul, N., Di Forti, M., Aas, M., D'Albenzio, A., Di Nicola, M., Fisher, H., Handley, R., Marques, T. R., et al. (2010) · Schizophrenia Research
Stress Responses and CortisolSchizophrenia research and treatment
Cited by 278
- Verified
Benzodiazepines: Risks and Benefits. A Reconsideration
Baldwin, D. S., Aitchison, K., Bateson, A., Curran, H. V., Davies, S., Leonard, B., Nutt, D. J., Stephens, D. N., & Wilson, S. (2013) · Journal of Psychopharmacology
Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPharmaceutical Practices and Patient Outcomes
Cited by 249
- Verified
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-α and ribavirin treatment
Bull, S. J., Huezo-Diaz, P., Binder, E. B., Cubells, J. F., Ranjith, G., Maddock, C., Miyazaki, C., Alexander, N., Hotopf, M., Cleare, A. J., et al. (2009) · Molecular Psychiatry
Tryptophan and brain disordersHepatitis C virus research
Cited by 228
- Verified
Genetic predictors of response to antidepressants in the GENDEP project
Uher, R., Huezo-Diaz, P., Perroud, N., Smith, R., Rietschel, M., Mors, O., Hauser, J., Maier, W., Kozel, D., Henigsberg, N., et al. (2009) · The Pharmacogenomics Journal
Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior
Cited by 226
- Verified
Serum and gene expression profile of cytokines in first-episode psychosis
Di Nicola, M., Cattaneo, A., Hepgul, N., Di Forti, M., Aitchison, K. J., Janiri, L., Murray, R. M., Dazzan, P., Pariante, C. M., & Mondelli, V. (2013) · Brain Behavior and Immunity
Tryptophan and brain disordersSchizophrenia research and treatment
Cited by 217
- Verified
MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes
Lopez, J. P., Fiori, L. M., Cruceanu, C., Lin, R., Labonte, B., Cates, H. M., Heller, E. A., Vialou, V., Ku, S. M., Gerald, C., et al. (2017) · Nature Communications
Treatment of Major DepressionMicroRNA in disease regulation
Cited by 201
- Verified
Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis
Mondelli, V., Pariante, C. M., Navari, S., Aas, M., D'Albenzio, A., Di Forti, M., Handley, R., Hepgul, N., Marques, T. R., Taylor, H., et al. (2010) · Schizophrenia Research
Schizophrenia research and treatmentStress Responses and Cortisol
Cited by 144
- Verified
Abnormal cortisol awakening response predicts worse cognitive function in patients with first-episode psychosis
Aas, M., Dazzan, P., Mondelli, V., Toulopoulou, T., Reichenberg, A., Di Forti, M., Fisher, H. L., Handley, R., Hepgul, N., Marques, T., et al. (2011) · Psychological Medicine
Stress Responses and CortisolSchizophrenia research and treatment
Cited by 124
- Verified
Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline
Uher, R., Dernovsek, M. Z., Mors, O., Hauser, J., Souery, D., Zobel, A., Maier, W., Henigsberg, N., Kalember, P., Rietschel, M., et al. (2011) · Journal of Affective Disorders
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 112
- Verified
Genomewide Association Scan of Suicidal Thoughts and Behaviour in Major Depression
Schosser, A., Butler, A. W., Ising, M., Perroud, N., Uher, R., Ng, M. Y., Cohen-Woods, S., Craddock, N., Owen, M. J., Korszun, A., et al. (2011) · PLoS ONE
Genetic Associations and EpidemiologySuicide and Self-Harm Studies
Cited by 108
- Verified
Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population
Wolff, K., Tsapakis, E. M., Winstock, A. R., Hartley, D., Holt, D., Forsling, M. L., & Aitchison, K. J. (2006) · Journal of Psychopharmacology
Psychedelics and Drug StudiesElectrolyte and hormonal disorders
Cited by 108
- Verified
Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial
Perroud, N., Uher, R., Marusic, A., Rietschel, M., Mors, O., Henigsberg, N., Hauser, J., Maier, W., Souery, D., Placentino, A., et al. (2009) · BMC Medicine
Suicide and Self-Harm StudiesTreatment of Major Depression
Cited by 57
- Verified
Genome-wide association analysis of copy number variation in recurrent depressive disorder
Rucker, J. J. H., Breen, G., Pinto, D., Pedroso, I., Lewis, C. M., Cohen-Woods, S., Uher, R., Schosser, A., Rivera, M., Aitchison, K. J., et al. (2013) · Molecular Psychiatry
Genomic variations and chromosomal abnormalitiesGenetic Associations and Epidemiology
Cited by 51
- Verified
Investigation of blood mRNA biomarkers for suicidality in an independent sample
Mullins, N., Hodgson, K., Tansey, K. E., Perroud, N., Maier, W., Mors, O., Rietschel, M., Hauser, J., Henigsberg, N., Souery, D., et al. (2014) · Translational Psychiatry
Suicide and Self-Harm StudiesTreatment of Major Depression
Cited by 30
- Verified
Genetic disposition to inflammation and response to antidepressants in major depressive disorder
Zwicker, A., Fabbri, C., Rietschel, M., Hauser, J., Mors, O., Maier, W., Zobel, A., Farmer, A., Aitchison, K. J., McGuffin, P., et al. (2018) · Journal of Psychiatric Research
Treatment of Major DepressionTryptophan and brain disorders
Cited by 28
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free